BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29195273)

  • 1. Proteoform Suite: Software for Constructing, Quantifying, and Visualizing Proteoform Families.
    Cesnik AJ; Shortreed MR; Schaffer LV; Knoener RA; Frey BL; Scalf M; Solntsev SK; Dai Y; Gasch AP; Smith LM
    J Proteome Res; 2018 Jan; 17(1):568-578. PubMed ID: 29195273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating Proteoform Families from Proteoform Intact-Mass and Lysine-Count Measurements.
    Shortreed MR; Frey BL; Scalf M; Knoener RA; Cesnik AJ; Smith LM
    J Proteome Res; 2016 Apr; 15(4):1213-21. PubMed ID: 26941048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database.
    Dai Y; Buxton KE; Schaffer LV; Miller RM; Millikin RJ; Scalf M; Frey BL; Shortreed MR; Smith LM
    J Proteome Res; 2019 Oct; 18(10):3671-3680. PubMed ID: 31479276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoform Analysis and Construction of Proteoform Families in Proteoform Suite.
    Schaffer LV; Shortreed MR; Smith LM
    Methods Mol Biol; 2022; 2500():67-81. PubMed ID: 35657588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding Proteoform Identifications in Top-Down Proteomic Analyses by Constructing Proteoform Families.
    Schaffer LV; Shortreed MR; Cesnik AJ; Frey BL; Solntsev SK; Scalf M; Smith LM
    Anal Chem; 2018 Jan; 90(2):1325-1333. PubMed ID: 29227670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating Escherichia coli Proteoform Families Using Intact-Mass Proteomics and a Global PTM Discovery Database.
    Dai Y; Shortreed MR; Scalf M; Frey BL; Cesnik AJ; Solntsev S; Schaffer LV; Smith LM
    J Proteome Res; 2017 Nov; 16(11):4156-4165. PubMed ID: 28968100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Human Proteoform Families from 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Top-Down Proteomic Data.
    Schaffer LV; Anderson LC; Butcher DS; Shortreed MR; Miller RM; Pavelec C; Smith LM
    J Proteome Res; 2021 Jan; 20(1):317-325. PubMed ID: 33074679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
    Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
    J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore.
    Kou Q; Zhu B; Wu S; Ansong C; Tolić N; Paša-Tolić L; Liu X
    J Proteome Res; 2016 Aug; 15(8):2422-32. PubMed ID: 27291504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms.
    Schaffer LV; Tucholski T; Shortreed MR; Ge Y; Smith LM
    Anal Chem; 2019 Sep; 91(17):10937-10942. PubMed ID: 31393705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Quantification of Murine Mitochondrial Proteoforms Using an Integrated Top-Down and Intact-Mass Strategy.
    Schaffer LV; Rensvold JW; Shortreed MR; Cesnik AJ; Jochem A; Scalf M; Frey BL; Pagliarini DJ; Smith LM
    J Proteome Res; 2018 Oct; 17(10):3526-3536. PubMed ID: 30180576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Homologous Proteins and Proteoforms.
    Malioutov D; Chen T; Airoldi E; Jaffe J; Budnik B; Slavov N
    Mol Cell Proteomics; 2019 Jan; 18(1):162-168. PubMed ID: 30282776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine Counting via Isotopic Chemical Labeling for Intact Mass Proteoform Identifications in Tissue.
    Pavek JG; Frey BL; Frost DC; Gu TJ; Li L; Smith LM
    Anal Chem; 2023 Oct; 95(41):15245-15253. PubMed ID: 37791746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Quantification of Proteoforms by Mass Spectrometry.
    Schaffer LV; Millikin RJ; Miller RM; Anderson LC; Fellers RT; Ge Y; Kelleher NL; LeDuc RD; Liu X; Payne SH; Sun L; Thomas PM; Tucholski T; Wang Z; Wu S; Wu Z; Yu D; Shortreed MR; Smith LM
    Proteomics; 2019 May; 19(10):e1800361. PubMed ID: 31050378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Top-Down Proteomics Enables Comparative Analysis of Brain Proteoforms Between Mouse Strains.
    Davis RG; Park HM; Kim K; Greer JB; Fellers RT; LeDuc RD; Romanova EV; Rubakhin SS; Zombeck JA; Wu C; Yau PM; Gao P; van Nispen AJ; Patrie SM; Thomas PM; Sweedler JV; Rhodes JS; Kelleher NL
    Anal Chem; 2018 Mar; 90(6):3802-3810. PubMed ID: 29481055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoforms and Proteoform Families: Past, Present, and Future.
    Smith LM
    Methods Mol Biol; 2022; 2500():1-4. PubMed ID: 35657582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.
    Kou Q; Wu S; Tolic N; Paša-Tolic L; Liu Y; Liu X
    Bioinformatics; 2017 May; 33(9):1309-1316. PubMed ID: 28453668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top-Down Mass Spectrometry Data Analysis Using TopPIC Suite.
    Choi IK; Liu X
    Methods Mol Biol; 2022; 2500():83-103. PubMed ID: 35657589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Quantification of Proteoforms in Complex Samples by Proteoform Reaction Monitoring.
    Huang CF; Kline JT; Negrão F; Robey MT; Toby TK; Durbin KR; Fellers RT; Friedewald JJ; Levitsky J; Abecassis MMI; Melani RD; Kelleher NL; Fornelli L
    Anal Chem; 2024 Feb; 96(8):3578-3586. PubMed ID: 38354049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TopFD: A Proteoform Feature Detection Tool for Top-Down Proteomics.
    Basharat AR; Zang Y; Sun L; Liu X
    Anal Chem; 2023 May; 95(21):8189-8196. PubMed ID: 37196155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.